Utama › Keadaan Pasca-COVID (Long COVID) › Alabama
Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Alabama
7 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Anniston
Mengambil pesertaFasa 1
Umur 65 hingga 85 · Semua jantina · Dikemas kini 30 Jun 2026 · NCT07464314REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Mei 2026 · NCT05218083Long COVID Brain Fog: Cognitive Rehabilitation Trial
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06095297Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
- AFC Montclair, Birmingham
- AFC Madison, Madison
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 2 ke atas · Semua jantina · Dikemas kini 2 Okt 2025 · NCT06744660Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
- University of South Alabama, Mobile
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Mei 2021 · NCT04445285Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.